Drew Babin analyst

Currently out of the existing stock ratings of Drew Babin, 17 are a BUY (73.91%), 6 are a HOLD (26.09%).

Drew Babin

Work Performance Price Targets & Ratings Chart

Analyst Drew Babin, carries an average stock price target met ratio of 100% that have a potential upside of 56.08% achieved within 732 days. Previously, Drew Babin worked at BAIRD.

Drew Babin’s has documented 49 price targets and ratings displayed on 11 stocks.

Most recent stock forecast was given on ELS, Equity Lifestyle Properties at 22-Jul-2020.

Wall Street Analyst Drew Babin

Analyst best performing recommendations are on GMRE (GLOBAL MEDICAL REIT).
The best stock recommendation documented was for BRG (BLUEROCK RESIDENTIAL GROWTH) at 3/17/2020. The price target of $8 was fulfilled within 83 days with a profit of $0.94 (13.31%) receiving and performance score of 1.6.

Average potential price target upside

BRG Bluerock Residential Growth IRET Investors Real Estate Trust CPT Camden Property Trust AMH American Homes 4 Rent AVB AvalonBay Communities ELS Equity Lifestyle Properties ESS Essex Property Trust GMRE Global Medical REIT MPW Medical Properties Trust SUI Sun Communities UDR UDR

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 30-Dec-2021

$27

4 years 10 months 8 days ago
(01-Jan-2022)

1/2 (50%)

$0.88 (3.37%)

17

Hold Since 22-Dec-2021

4 years 10 months 13 days ago
(27-Dec-2021)

1/1 (100%)

$2.04 (18.61%)

240

Sell Since 11-Jan-2021

$9.5

$-17.1 (-64.29%)

$9.5

5 years 6 months 19 days ago
(21-Apr-2021)

2/2 (100%)

$0.56 (6.26%)

68

Hold Since 10-Jun-2020

$11

$-15.6 (-58.65%)

$9

5 years 8 months 28 days ago
(12-Feb-2021)

7/7 (100%)

$0.4 (3.77%)

1516

Buy Since 17-Mar-2020

$8

$-18.6 (-69.92%)

$11

6 years 7 months 23 days ago
(17-Mar-2020)

2/2 (100%)

$0.94 (13.31%)

500

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?